| Place of Origin: | China |
|---|---|
| Brand Name: | Senwayer |
| Certification: | ISO, 9001, USP |
| Model Number: | 61825-94-3 |
| Minimum Order Quantity: | 10grams |
| Price: | Discount is possible if your order is big enough |
| Packaging Details: | 10g, 20g, 50g , 100g, 500g. 1kg, 10kg |
| Delivery Time: | within 2 working days |
| Payment Terms: | T/T in advance, Money Gram, Western Union, Bank Transfer. |
| Supply Ability: | 1000kg/month |
| CAS: | 61825-94-3 | Apparence: | Almost White Crystalline Powder |
|---|---|---|---|
| Purity: | 99% | Stock: | Enough Stock |
| Grade: | Pharma Grade | ||
| High Light: | Oxaliplatin Crystalline Powder,Antineoplastic Drugs Oxaliplatin CAS 61825-94-3,CAS 61825-94-3 Pharmaceutical Raw Material |
||
Antineoplastic Drugs Oxaliplatin CAS 61825-94-3
Quick detail
Product Name: Oxaliplatin
Synonyms: oxalatoplatinum;oxaliplatino;Oxaliplatin99%;OxaliplatinEp5;(1R-trans)-1,2-Cyclohexanediamine, platinum complex;Dacplat;Eloxatin;Elplat
CAS: 61825-94-3
MF: C8H14N2O4Pt
MW: 397.29
EINECS: 621-248-1
Product Categories: Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;Antineoplastic;Intermediates & Fine Chemicals;Pharmaceuticals;APIs;Amines;Heterocycles;chemical reaction,pharm,electronic,materials;PRAXILENE;Inhibitors
Mol File: 61825-94-3.mol
Description
Oxaliplatin, also called Eloxatin or Eloxatine, is a platinum derivative.
Used clinically to treat patients with metastatic colorectal cancer after failure of fluorouracil treatment, can be used alone or in combination with 5-fluorouracil. It is the third-generation platinum antitumor compound after cisplatin and carboplatin, and so far the only platinum-based drug with significant effectiveness against colorectal cancer. It also inhibits proliferation of ovarian cancer and melanoma cell lines.
Uses
Oxaliplatin, also called Eloxatin or Eloxatine, is a platinum derivative.
Used clinically to treat patients with metastatic colorectal cancer after failure of fluorouracil treatment, can be used alone or in combination with 5-fluorouracil. It is the third-generation platinum antitumor compound after cisplatin and carboplatin, and so far the only platinum-based drug with significant effectiveness against colorectal cancer. It also inhibits proliferation of ovarian cancer and melanoma cell lines.
